Ottawa blocking Canadians’ access to innovative drugs
Health Canada’s revisions to the drug-pricing review board will delay or prevent access to new drugs
Read MoreHealth Canada’s revisions to the drug-pricing review board will delay or prevent access to new drugs
Read MoreConcerns about density are misplaced – Toronto and Vancouver have plenty of room to grow up and grow more affordable
Read MoreIntroducing new regulations and taxes to diminish executive pay will ultimately damage the Canadian economy
Read MoreThe province already lags behind many American states in key policy areas, including regulatory compliance and taxation
Read MoreThe 2016 CPP reforms were solutions in search of a problem – and don’t even solve the imagined problem
Read More